Mobidiag, Biomedica Collaborate
News Sep 07, 2016
Mobidiag Ltd has announced an agreement with Biomedica Medizinprodukte GmbH & Co KG for the distribution of the Amplidiag® product line. Under this new agreement Biomedica Medizinprodukte becomes the exclusive distributor of Amplidiag®, in vitro diagnostics for gastrointestinal infections, in Central and Eastern Europe (Austria, Bosnia & Herzegovina, Bulgaria, Croatia, Czech Republic, Hungary, Macedonia, Poland, Romania, Serbia, Slovakia, Slovenia).
“Since Mobidiag’s inception, we have been focusing our activity towards Nordic region and France mainly. Three months ago, we have started developing our distribution network by extending our European coverage to Spain and Benelux. We are very pleased today to expand Amplidiag accessibility to Central and Eastern Europe with the support of our partner, Biomedica Medizinprodukte” said Tuomas Tenkanen, CEO at Mobidiag.
“Rapid and reliable detection of gastrointestinal infections is crucial for preventing transmission of contagious pathogens. With Amplidiag products, we will ensure the distribution of innovative, quality products that will significantly impact infection control” said Dr. Michaela Weblacher, Executive Vice President at Biomedica.
The distribution agreement is effective immediately and covers all Amplidiag® products (Amplidiag® H. pylori+ClariR, Amplidiag® Stool Parasites, Amplidiag® CarbaR+VRE, Amplidiag® C. difficile+027, Amplidiag® Bacterial GE, Amplidiag® Easy and upcoming Amplidiag® Viral GE).
Self-powered, Paper-based Electrochemical Devices Developed for POC DiagnosticsNews
The new paper-based diagnostic device detects biomarkers and identifies diseases by performing electrochemical analyses, and the assays change color to indicate specific test results.READ MORE
Using Saliva to Diagnose ZikaNews
By analyzing the saliva of a pregnant mother infected with Zika and her twins, researchers were able to pinpoint the specific protein signature for Zika that is present in saliva, creating potential to use this signature as an effective way to screen for exposure.READ MORE